VeriScreen is a nationally recognized and NAPBS certified professional background screening leader with 20-plus years of experience currently focusing in three very specialized and critical sectors:1. Affordable Housing & Residential Property Management2. Staffing Companies - Regional & National3. Volunteer Programs of National Size and InfluenceWith our trade-marked Person Search Plus Tool, VeriScreen guarantees more hits and data than any of our competitors, ensuring the highest quality information and ROI for our valued and loyal clients. Come check VeriScreen out and let us demonstrate our unique Value and Guarantees to you!VeriScreen's 5 Business Guarantees:1. More Hits Than Anyone Else2. No False Positives - We Verify Each Hit3. Better Turnaround Time4. Experienced Researchers Answer the Phones Live - No Menu Trees5. Complete Customer Satisfaction

Emerge Diagnostics has developed an FDA-registered, class-II diagnostic device called an Electrodiagnostic Functional Assessment (EFA) that can age and evaluate muscle activity, distinguish between acute versus chronic injury, and objectively quantify effort. The EFA-Soft Tissue Management (STM) Program is a patent-pending process that has been specifically designed for an employer’s current workforce, as well as new hires, in compliance with ADAAA and EEOC regulations. It begins with a baseline assessment, which is not read, but instead is stored in a secured database. When a work-related injury is reported, a post-injury assessment is performed, at which time the information collected from the baseline assessment is compared to the data from the post-injury assessment. The baseline data is read only if an injury occurs and the post-loss assessment is performed. The EFA-STM Program allows employers to establish pre-injury status and provides the objective data necessary to accurately diagnose soft-tissue injuries which ultimately leads to better treatment outcomes for employees and patients.

Oakley was created for world-class athletes, those who see the limits of possibility as just another challenge. Their dedication drives us to look beyond the conventional ideas of industry standards. It’s in our DNA to identify problems, create inventions, and wrap those inventions in art. And simply to make things better than anyone thought possible.

Responsible for organic growth in SE and multiple national innovative partnerships. Leader on eScreen's management team mapping strategies and tactics for one on INC's fastest growing companies 2008-2012. * Part of eScreen leadership team that created $360M buy-out at 13 times EBITDA.* Developed groundbreaking outsourcing tactics into the company's fastest growing revenue stream equating to over a third of the organization's total revenue.

Led team of 12 sales professions focused on selling backgrounds, Drug Testing, and Biometric solutions to Enterprose companies on-boarding applicants into their organizations. Responsible for $60M in client based business and $8M in annual organic growth.

Managed $200M in revenue, 4 regional managers, and 50 sales professionals selling clinical testing directly to Florida-based physicians

Spearheaded global launch of both GSK's International manufacturing division, and leadership planning process while based at national headquarters in London, England. Diverse experience and achievement in business development, human resources development, and global operations development.